Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse Events.
Nagase FN, Fukui S, Takizawa N, Yamaguchi T, Oda N, Inokuchi H, Ito T, Watanabe M, Suda M, Haji Y, Suyama Y, Rokutanda R, Minoda M, Nomura A, Uechi E, Tamaki H.
Nagase FN, et al. Among authors: fukui s.
J Rheumatol. 2024 Dec 1:jrheum.2024-0612. doi: 10.3899/jrheum.2024-0612. Online ahead of print.
J Rheumatol. 2024.
PMID: 39547687